Dr. Wu graduated from the Ross Univ, Sch of Med, Roseau, Dominica in 2002. She works in Las Vegas, NV and specializes in General Practice and Internal Medicine.
Kaiser Permanente Medical GroupKaiser Permanente Downy Medical Center 9333 Imperial Hwy, Downey, CA 90242 5626579000 (phone), 5626574522 (fax)
Education:
Medical School Johns Hopkins University School of Medicine Graduated: 2005
Languages:
English
Description:
Dr. Wu graduated from the Johns Hopkins University School of Medicine in 2005. She works in Downey, CA and specializes in Anatomic Pathology & Clinical Pathology. Dr. Wu is affiliated with Kaiser Permanente Medical Center.
Jan 2014 to 2000 Behavioral TherapistTELACU Los Angeles, CA Jul 2011 to Jan 2014 Residential Service CoordinatorExceptional Children's Foundation Culver City, CA Jun 2010 to Jul 2011 Work Readiness Program Case ManagerAsian Rehabilitation Service, Inc Los Angeles, CA Nov 2008 to Jun 2010 Supportive Employment Program CoordinatorInclusion Education & Community Partnership Oxnard, CA Sep 2008 to Nov 2008 Behavior TherapistFamilies First Inc Davis, CA Apr 2007 to Jul 2008 Substitute teacher/ Counselor II
Education:
University of Southern California Los Angeles, CA Sep 2012 to Aug 2014 Masters of Social Work in Military Social WorkGeorge Washington University Washington, DC Sep 2009 to Aug 2011 Master of Arts in Education and Human DevelopmentUniversity of California Davis, CA Bachelor of Arts in Psychology
Julie Adams Wu - Columbia MD, US James J. Mond - Silver Spring MD, US Scott M. Walsh - Germantown MD, US Anjali G. Shah - North Potomac MD, US Tatyana I. Chanturiya - Rockville MD, US
Assignee:
BIOSYNEXUS INCORPORATED - Gaithersburg MD
International Classification:
A61K 38/48 A61P 31/04
US Classification:
424 9467
Abstract:
Methods for treating patients in which damaged tissue or an indwelling prosthetic device or catheter has a bacterial biofilm growing thereon, to at least partially disrupt said biofilm, by administering at least one antibacterial enzyme that is lethal or damaging to the biofilm-forming bacteria in an amount that is effective to at least partially disrupt the biofilm upon contact therewith. Methods for prophylactically treating a patient, and methods for disinfecting or sterilizing a surface ex-vivo to remove a biofilm or prevent biofilm growth are also disclosed, as well as implantable articles susceptible to biofilm growth to which a prophylactic coating of an antibacterial enzyme has been applied.